Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional near-infrared spectroscopy (fNIRS). By comparing brain activity across different groups and relating it to symptom severity, this study aims to improve our understanding of how these conditions affect the brain.

Eligibility criteria

Qualifiers

18 years and older

Ability to provide written informed consent

Adequate cognitive and language abilities to understand and complete study tasks, including clinical assessments and fNIRS procedures

Confirmed clinical diagnosis of major depressive disorder, bipolar disorder, or mild cognitive impairment (MCI)

Disqualifiers

Active primary psychotic or substance use disorders (except nicotine dependence) within the past year

Any severe or unstable medical condition that could interfere with participation or data collection

Any active neurological condition (including seizure disorder, traumatic brain injury, stroke) that could affect cognitive functioning or brain imaging results

Inability to comply with study procedures, including cognitive testing, fNIRS assessment, or other assessments required by the protocol

Trial design

Treatments tested in this trial

  • Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels.

Treatment groups

200 Participants
are divided into 4 treatment groups

Sponsors and collaborators